Hailir Pharmaceutical Group Co., Ltd. (hereinafter referred to as hailir), founded in 1999, is a national designated pesticide and fertilizer production enterprise. It is a professional and global large-scale agrochemical group integrating R & D, production, sales and technical services of pesticides, intermediates and new fertilizers. It was listed on the main board A-share of Shanghai Stock Exchange on January 12, 2017, with stock code 603639. In the first three quarters of 2022, operating income reached 3.803 billion yuan, an increase of 47.2 % year-on-year.

     The group currently employs more than 3200 people and has a world-class production base of nicotine and Methoxyacrylate pesticides. It has five production bases under its jurisdiction: Qingdao hailir pharmaceutical, Qingdao Otis biology, Qingdao kaiyuanxiang chemical, Shandong hailir chemical and Qingdao hengning biology. Through good operation and management, it has reached a production capacity of 40000 tons of original drugs and 75000 tons of preparations, Continuously and stably provide high-quality products and services to global partners. At the same time, it has nine major brand operating companies, which have strong positions in the leading camp of the industry, and its products are deeply recognized by customers.